Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1.
about
Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.In Silico Modeling of Liver Metabolism in a Human Disease Reveals a Key Enzyme for Histidine and Histamine Homeostasis.Molecular therapy of primary hyperoxaluria.Lessons learned from lung and liver in-vivo gene therapy: implications for the future
P2860
Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Helper-dependent adenoviral ve ...... primary hyperoxaluria type 1.
@en
type
label
Helper-dependent adenoviral ve ...... primary hyperoxaluria type 1.
@en
prefLabel
Helper-dependent adenoviral ve ...... primary hyperoxaluria type 1.
@en
P2093
P2860
P356
P1433
P1476
Helper-dependent adenoviral ve ...... f primary hyperoxaluria type 1
@en
P2093
N Brunetti-Pierri
P Annunziata
R Castello
P2860
P2888
P304
P356
10.1038/GT.2015.107
P577
2015-12-24T00:00:00Z